Armata Pharmaceuticals (ARMP) EPS (Weighted Average and Diluted) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.33% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -1.99% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 45.47% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -99.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.16% |
| Dec 31, 2025 | -127.84% |
| Sep 30, 2025 | -45.55% |
| Jun 30, 2025 | -20.06% |
| Mar 31, 2025 | 12.64% |
| Dec 31, 2024 | -8.03% |
| Sep 30, 2024 | 11.99% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -36.72% |
| Dec 31, 2023 | -15.17% |
| Sep 30, 2023 | -40.51% |
| Jun 30, 2023 | 13.21% |
| Dec 31, 2022 | 12.97% |
| Sep 30, 2022 | 30.98% |
| Jun 30, 2022 | 27.77% |
| Dec 31, 2021 | 1.41% |
| Sep 30, 2021 | 28.43% |
| Jun 30, 2021 | 28.36% |
| Dec 31, 2020 | -0.52% |
| Sep 30, 2020 | -51.02% |
| Jun 30, 2020 | 43.74% |
| Dec 31, 2019 | 60.14% |
| Sep 30, 2019 | 39.09% |
| Jun 30, 2019 | 55.48% |
| Dec 31, 2018 | 23.69% |
| Sep 30, 2018 | -25.99% |
| Jun 30, 2018 | -27.25% |
| Dec 31, 2017 | 6.96% |
| Sep 30, 2017 | 53.58% |
| Jun 30, 2017 | -32.33% |
| Dec 31, 2016 | -291.31% |
| Sep 30, 2016 | -87.50% |
| Jun 30, 2016 | -265.62% |